Clinical Trial Update: An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial of aripiprazole in children and adolescents with bipolar disorder has completed, with the document providing an update on the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Abilify (aripiprazole) (aripiprazole)

Snippet

Sponsor: University of Cincinnati | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED